Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. Export

@article{citeulike:257470, abstract = {OBJECTIVE: We sought to identify factors associated with interest in receiving therapy for hepatitis C virus (HCV) infection among HCV-infected injection drug users (IDUs) in 3 United States cities. METHODS: IDUs aged 18-35 years who were HCV-infected and seronegative for human immunodeficiency virus underwent surveys on behaviors, experience, and interest in treatment for HCV infection and readiness to quit drug use. RESULTS: Among treatment-naive IDUs (n=216), 81.5\% were interested in treatment for HCV infection, but only 27.3\% had seen a health-care provider since receiving a diagnosis of HCV infection. Interest in treatment for HCV infection was greater among IDUs with a high perceived threat of progressive liver disease, those with a usual source of care, those without evidence of alcohol dependence, and those with higher readiness scores for quitting drug use. Interest in treatment for HCV infection was 7-fold higher among IDUs who were told by their health-care provider that they were at risk for cirrhosis or liver cancer. CONCLUSIONS: Improving provider-patient communication and integrating treatments for substance abuse and HCV may increase the proportion of IDUs who initiate treatment for HCV infection.}, address = {Department of Family and Preventive Medicine, Division of International Health and Cross-Cultural Medicine, University of California, San Diego, California 92093, USA. sstrathdee@ucsd.edu}, author = {Strathdee, S. A. and Latka, M. and Campbell, J. and O'Driscoll, P. T. and Golub, E. T. and Kapadia, F. and Pollini, R. A. and Garfein, R. S. and Thomas, D. L. and Hagan, H. and {}}, citeulike-article-id = {257470}, citeulike-linkout-0 = {http://dx.doi.org/10.1086/427445}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/15768339}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=15768339}, day = {15}, doi = {10.1086/427445}, issn = {1537-6591}, journal = {Clin Infect Dis}, keywords = {hcv, health, idu, interferon, treatment, young}, month = {April}, posted-at = {2005-07-16 06:33:38}, priority = {5}, title = {Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.}, url = {http://dx.doi.org/10.1086/427445}, volume = {40 Suppl 5}, year = {2005} }

TY - JOUR ID - citeulike:257470 L3 - citeulike-article-id:257470 N2 - OBJECTIVE: We sought to identify factors associated with interest in receiving therapy for hepatitis C virus (HCV) infection among HCV-infected injection drug users (IDUs) in 3 United States cities. METHODS: IDUs aged 18-35 years who were HCV-infected and seronegative for human immunodeficiency virus underwent surveys on behaviors, experience, and interest in treatment for HCV infection and readiness to quit drug use. RESULTS: Among treatment-naive IDUs (n=216), 81.5% were interested in treatment for HCV infection, but only 27.3% had seen a health-care provider since receiving a diagnosis of HCV infection. Interest in treatment for HCV infection was greater among IDUs with a high perceived threat of progressive liver disease, those with a usual source of care, those without evidence of alcohol dependence, and those with higher readiness scores for quitting drug use. Interest in treatment for HCV infection was 7-fold higher among IDUs who were told by their health-care provider that they were at risk for cirrhosis or liver cancer. CONCLUSIONS: Improving provider-patient communication and integrating treatments for substance abuse and HCV may increase the proportion of IDUs who initiate treatment for HCV infection. JF - Clin Infect Dis SN - 1537-6591 AD - Department of Family and Preventive Medicine, Division of International Health and Cross-Cultural Medicine, University of California, San Diego, California 92093, USA. sstrathdee@ucsd.edu TI - Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. VL - 40 Suppl 5 KW - hcv KW - health KW - idu KW - interferon KW - treatment KW - young AU - Strathdee, SA AU - Latka, M AU - Campbell, J AU - O'Driscoll, PT AU - Golub, ET AU - Kapadia, F AU - Pollini, RA AU - Garfein, RS AU - Thomas, DL AU - Hagan, H PY - 2005/04/15/ UR - http://dx.doi.org/10.1086/427445 ER -